Nuevolution AB (publ) announces timing for the third quarter release and webcast


Stockholm, 6 May 2016 – Nuevolution AB (publ) (NUE.ST) announces today that it
will report its third quarter 2015/16 financial results on Tuesday 10 May at
9.00h CET.

On Tuesday 10 May at 14:00 CET, the company’s executive management will host a
conference call and webcast discussion of the results and provide an update on
the pipeline programs and partnering activities. Access to the event can be
obtained as follows:

LIVE access on Tuesday 10 May at 14:00 CET

Telephone numbers:

SE: +46 85 664 2669

DK: +45 8233 3178

UK: +44 20 3008 9808

US: +1 855 7532 235

Webcast available at www.nuevolution.com in the Investors section and at
www.financialhearings.com

REPLAY access

Webcast replay will be available on Nuevolution’s website at www.nuevolution.com
in the Investors section and at www.financialhearings.com

For more information, please contact:

Alex Haahr Gouliaev, CEO

Phone: +45 3913 0902

Email: ahg@nuevolution.com

Henrik Damkjær Simonsen, CFO

Phone: +45 3913 0947

Email: hs@nuevolution.com

Information about Nuevolution AB (publ)

Nuevolution AB (publ) is a leading small molecule drug discovery biotech company
founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners
its discovery platform and programs with pharmaceutical and biotechnology
companies to seek future benefit of patients in need of novel medical treatment
option. Nuevolution’s internal programs are focused on therapeutically important
targets within inflammation, oncology and immuno-oncology.

Nuevolution AB (publ) is required to disclose the information provided herein
pursuant to the Securities Markets Act and/or the Financial Instruments Trading
Act. The information was sent for publication on 6 May 13.00 (CET)

Nuevolution AB (publ) is listed at Nasdaq First North in Stockholm, Sweden
(ticker: NUE). Västra Hamnen Corporate Finance AB acts as Certified Advisor to
Nuevolution AB (publ). More information about Nuevolution can be found on:
www.nuevolution.com

Attachments

05064268.pdf